PIII
The table below shows P3 Health Partners's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$27.47M | -$33.47M | -$20.03M | -$23.72M | -$27.78M | -$13.12M |
| Capital expenditure | - | - | $0.00 | $464.00K | $877.00K | $656.18K |
| Investing cash flow | -$43.00K | $0.00 | $0.00 | -$464.00K | -$1.15M | -$729.67K |
| Dividends paid | - | - | - |
P3 Health Partners reported operating cash flow of -$91.24M for fiscal year 2025. That is up 17.2% from -$110.13M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$28.29M (FY 2019) to -$91.24M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $27.80M | $30.66M | $11.40M | $14.10M | -$1.21M | -$22.22K |